Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

IMMFF

Omni Bridgeway (PK) (IMMFF)

Omni Bridgeway Ltd (PK)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IMMFF

1

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
05/07/2022	01h40	TipRanks	Goldman Sachs Sticks to Their Buy Rating for Omni Bridgeway (IMMFF)	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
15/03/2022	16h35	TipRanks	Omni Bridgeway (IMMFF) Receives a Buy from Goldman Sachs	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
17/01/2013	16h25	Edgar (US Regulatory)	Revocation of Exchange Act Registration Pursuant to Section 12(j) (revoked)	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
17/01/2013	06h00	OTC Markets	Revoked Security	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
22/12/2012	06h00	OTC Markets	Tier Change	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
20/12/2012	06h00	OTC Markets	Suspended Security	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
20/12/2012	06h00	OTC Markets	Caveat Emptor Status Change	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
10/08/2011	11h00	GlobeNewswire Inc.	Immune Network to Start Clinical Trial of Oral Mycobacterium Vaccae in Tuberculosis Patients	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
09/07/2011	12h57	GlobeNewswire Inc.	Immunitor Presents V5 Trial Data and Receives Award at TB Conference in Hong Kong	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
07/07/2011	16h33	GlobeNewswire Inc.	Herbal TB Immunotherapy to be Presented at Hong Kong Conference	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
30/05/2011	16h14	GlobeNewswire Inc.	TB Immunotherapy Collaboration Agreement With Stirling Products and Zodiac Capital	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
03/03/2011	16h07	GlobeNewswire Inc.	Ekomed Agrees to Collaboration on TB Immunotherapy	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
28/02/2011	12h22	GlobeNewswire Inc.	Immunitor Presents Positive TB Treatment Data at African Conference	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
14/02/2011	11h57	GlobeNewswire Inc.	Immunitor CEO Joins Immune Network Board of Directors	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
24/01/2011	10h43	GlobeNewswire Inc.	Immunitor Releases Positive Results of TB Immunotherapy From Its Second Clinical Site	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
17/01/2011	11h22	GlobeNewswire Inc.	Immunitor Deal Terms Approved by New Board of Directors	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
30/12/2010	10h41	GlobeNewswire Inc.	Immunitor Publishes Interim Data From Phase IIb imm01 TB Trial	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
13/12/2010	16h10	GlobeNewswire Inc.	Immunitor Completes Business Trip to China and Presents at Chinese Academy of Science Annual TB Meeting	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
29/11/2010	13h38	GlobeNewswire Inc.	Immunitor Awarded the Key U.S. Patent Related to Oral Vaccine Technology Platform	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
15/11/2010	05h21	GlobeNewswire Inc.	Immunitor Completes Phase IIb imm01 Trial Enrollment and Plans Further Trials of V5	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
01/11/2010	14h42	GlobeNewswire Inc.	Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
25/10/2010	13h29	GlobeNewswire Inc.	Immunitor Therapy is a Potential Breakthrough Against Tuberculosis	USOTC:IMMFF	Omni Bridgeway Ltd (PK)
16/09/2010	15h58	GlobeNewswire Inc.	Immune Network Ltd. Announces Intent to Acquire Oral Vaccine Technology Platform	USOTC:IMMFF	Omni Bridgeway Ltd (PK)

Showing the most relevant articles for your search:USOTC:IMMFF

1

Deutsche Lufthansa

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen